PeptidePedia The community reference

Talk:Wuhan Wansheng Biotechnology

Discussion page·3 threads·1 archive

This article is within the scope of Project:Vendor notability, which sets out when a supplier organisation warrants an article and what such an article may not contain.
Supplier articles attract promotional editing. Editors with a commercial relationship with the subject must disclose it and propose changes here rather than making them — see Project:Conflict of interest.

This is the discussion page for the article Wuhan Wansheng Biotechnology. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

RfC: does a large report set support any conclusion?RfC

Request for comment. This discussion is advertised to the wider editorial community. Uninvolved editors are asked to comment on the question as framed in the opening statement, not on the conduct of the participants.

Request for comment. This organisation has by far the largest associated third-party report set on the wiki. Earlier revisions of the article described this as a strong testing record. It has also been described, in edits since reverted, as evidence of quality problems on the basis of the low tail.

Question: what, if anything, does a large self-selected report set support? Please address the selection mechanism rather than the totals. — RfC_Rasmus (talk) 10:14, 17 June 2025 (UTC)

Almost nothing about the material, and something about the documentation. The set is self-selected in at least two opposing directions and neither bias is quantified, so the central tendency is uninterpretable. What is interpretable is dispersion relative to organisations whose certificates are standardised — and dispersion is a property of reports, which is exactly what we have. — AnalyticalAnnie (talk) 13:42, 17 June 2025 (UTC)

Agree with Annie. I would add the base-rate point explicitly, because both sides of this dispute have got it wrong in the past: a larger set contains more low results and more high results. Anyone arguing from the count of low results alone is arguing from the size of the set. — TallySheetTad (talk) 09:27, 18 June 2025 (UTC)

Nothing, and the article should say so at length. This is the one supplier article where the interesting content is epistemological rather than descriptive. A reader who leaves understanding why the large data set does not settle the question has learned something they can apply to the other nineteen. — NPOV_Nadia (talk) 11:03, 19 June 2025 (UTC)

Nothing — and both previous framings should be treated as neutrality violations, not merely as errors. "Strong testing record" and "evidence of problems" are the same mistake with opposite signs. — PuffRemoverPax (talk) 15:31, 20 June 2025 (UTC)

Nothing about quality. One caveat: the existence of a large set is itself a fact about the organisation's market position and about purchaser behaviour towards it, and that is worth a sentence. It just is not a quality finding. — VerifyFirstVida (talk) 09:48, 23 June 2025 (UTC)

Closing. Clear consensus: the set supports no conclusion about material quality; it supports a limited comparative statement about dispersion of reported figures; and its existence is a notable fact in itself. Both prior framings are to be treated as neutrality problems. Written into §Independent testing record in those terms. — RfC_Rasmus (talk) 10:52, 28 June 2025 (UTC)

Standing note: what this article may not containResolved

Placing the standing note at the top of every supplier talk page so it does not have to be re-argued. Under Project:Vendor notability a supplier article may not contain: a price, an offer, a discount, a price list, any contact detail, or a shipping-outcome claim not attributed to a source.

Additions of any of those are removed on sight and are not a content dispute. — NPOV_Nadia (talk) 09:12, 4 July 2024 (UTC)

Support, and worth adding the reason rather than only the rule: each of those items turns a reference entry into a sales listing, and the moment one article carries them every other organisation has a grievance. — CoI_Corin (talk) 11:48, 4 July 2024 (UTC)

Support. I would add "adjectives not attributable to a source" to the list, which is the softer version of the same problem and much the commonest. — Hedgerow_Hal (talk) 10:23, 5 July 2024 (UTC)

Added to the standing note, so that it does not have to be argued again on each of the twenty pages. ✓ ResolvedNPOV_Nadia (talk) 08:57, 6 July 2024 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.
This page was last edited on 28 June 2025, by RfC_Rasmus. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).